Drug Use Criteria

You are here

Home » Resources » Drug Utilization Review Board » Drug Use Criteria

The DUR Board provides evaluation of criteria for drug coverage within the Texas Medicaid program.  These criteria are used in retrospective and prospective drug utilization review, and are based on the compendia and peer reviewed medical literature. Criteria and standards are periodically revised to ensure that they reflect prescribing recommendations of the current compendia and literature.  All files are in PDF format unless otherwise indicated.

  1. _Acetylcholinesterase Inhibitors (PDF)
  2. Aerosolized Agents - metered-dose inhalers: anti-cholinergic drugs
  3. Aerosolized Agents - metered-dose inhalers: inhaled anti-inflammatory drugs (corticosteroids)
  4. Aerosolized Agents - metered-dose inhalers: beta 2 adrenergic drugs (long-acting)
  5. Aerosolized Agents - metered-dose inhalers: beta 2 adrenergic drugs (short-acting)
  6. Angiotensin-Converting Enzyme Inhibitors
  7. Angiotensin II Receptor Antagonists
  8. Antidepressant Drugs
  9. Antidiabetic Agents (oral)
  10. Aprepitant
  11. Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications
  12. _Atypical Antipsychotics (long-acting injectable) (PDF)
  13. _Atypical Antipsychotics (oral) (PDF)
  14. _Benzodiazepines (oral, rectal) (PDF)
  15. _Complement Inhibitor and Enzyme/Protein Replacement Therapy (PDF)
  16. Cyclooxygenase-2 Inhibitors
  17. _Direct Oral Anticoagulants (PDF)
  18. Exenatide
  19. _Exogenous Insulin Products (PDF)
  20. Fentanyl
  21. Fluoroquinolones (oral)
  22. Gabapentin
  23. Histamine H2 - Receptor Antagonists
  24. _Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors (PDF)
  25. _Hydrocodone Bitartrate/Hydrocodone Polistirex (PDF)
  26. Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi)
  27. Ketorolac (oral)
  28. Leukotriene Receptor Antagonists
  29. _Low-dose Quetiapine (PDF)
  30. _Low Molecular - Weight Heparins (PDF)
  31. _Memantine (PDF)
  32. Mecasermin
  33. _Nebulized Bronchodilators (PDF)
  34. _Nitazoxanide (PDF)
  35. Non-sedating Antihistamines
  36. Non-steroidal anti-inflammatory drugs
  37. Pramlintide
  38. _Promethazine Use In Children Less Than 2 Years of Age (PDF)
  39. Proton Pump Inhibitors
  40. Rifaximin (Xifaxan)
  41. Sedative/Hypnotics
  42. Serotonin 5-HT3 Receptor Antagonists (oral)
  43. Serotonin 5-HT1B/1D Receptor Agonists
  44. Skeletal Muscle Relaxants
  45. _Topical Calcineurin Inhibitors - Pimecrolimus (Elidel) and Tacrolimus (Protopic) (PDF)
  46. _Tramadol (PDF)

Resources